Prairie Village, KS – July 28, 2022 –Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, today announced that Raymond (Chip) Richter has joined the company as Vice President of Reimbursement. Richter is a healthcare executive and leader with over two decades of experience in healthcare economics, reimbursement, health policy and government affairs. He will be responsible for leading Artio’s healthcare economics and reimbursement teams.
“We are pleased to welcome Chip to the Artio senior leadership team to help us navigate the complex healthcare economics and reimbursement environments in the US and other major global markets,” stated F. Nicholas Franano, MD, President and CEO of Artio Medical. “Reimbursement plays an increasingly important role in driving commercial success for medical devices and Chip’s proven track record of securing reimbursement for medical devices that reflects their true value to patients, physicians, hospitals, and payors will be critical to Artio as we work to bring our large portfolio of high value products to market.”
Richter has a passion for translating national policy trends into practical go-to-market strategies and successfully achieving company reimbursement goals. He joins Artio from iCAD, where he established healthcare economics and reimbursement programs in preparation for the company’s product launches in the cancer detection and treatment spaces, and was instrumental in helping iCAD navigate a new Medicare payment model for radiation oncology. Prior to iCAD, Richter held roles of increasing healthcare economics and reimbursement responsibility with PROCEPT BioRobotics, St Jude Medical, and Abbott Vascular. He holds a BA in Sociology and Philosophy from Cabrini College and a Master of Public Health (MPH) from Johns Hopkins University.
About Artio Medical
Artio Medical is a medical device company committed to developing innovative products for the treatment of peripheral vascular, neurovascular, and cardiovascular diseases. For more information, please visit www.artio.com.
